The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
Hong-My Nguyen, Dipongkor Saha Department of Immunotherapeutics and Biotechnology, Texas Tech University Health Sciences Center, School of Pharmacy, Abilene, TX, 79601, USACorrespondence: Dipongkor Saha Tel +1 325-6960583Email Dipongkor.saha@ttuhsc.eduAbstract: Glioblastoma (GBM) is a lethal primary...
Main Authors: | Nguyen HM, Saha D |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-02-01
|
Series: | Oncolytic Virotherapy |
Subjects: | |
Online Access: | https://www.dovepress.com/the-current-state-of-oncolytic-herpes-simplex-virus-for-glioblastoma-t-peer-reviewed-article-OV |
Similar Items
-
Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
by: Norah Aldrak, et al.
Published: (2021-06-01) -
Identification of 22 Novel Motifs of the Cell Entry Fusion Glycoprotein B of Oncolytic Herpes Simplex Viruses: Sequence Analysis and Literature Review
by: Fang Shi, et al.
Published: (2020-08-01) -
Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
by: Jayeeta Ghose, et al.
Published: (2021-03-01) -
Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study
by: Ravi N. Samy, et al.
Published: (2019-10-01) -
Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia
by: Abdoli, A., et al.
Published: (2022)